Recent studies on the role of SLC25A51 in cancers, show increased levels of SLC25A51 in multiple cancers, and furthermore loss of SLC25A51 decreased proliferation and apoptosis in two different cancer cell models [37, 38]. Here, SLC25A51 is linked to cancer.